This episode featuring James Mackay, President & CEO of Aristea Therapeutics. James provides insights on his experience with setting up a biotech and challenges associated, industry climate on spin off opportunities, Aristea’s pipeline, collaborations and US PRMA reforms.
Presenter: Aparna Krishnan
Contributors: James Mackay, President & CEO of Aristea Therapeutics
Producer: Operations team
About Aristea Therapeutics, a San Diego-based clinical-stage immunology-focused drug development company developing novel therapies for serious, rare inflammatory diseases.
Weekly Roundup: November 5, 2019
Weekly RoundUp: August 5, 2019
Weekly Roundup: July 29, 2019
Weekly Roundup: July 22, 2019
Weekly Roundup: July 1, 2019
Weekly Roundup: June 23, 2019
Weekly Roundup: June 16, 2019
Weekly Roundup: June 12, 2019
Weekly RoundUp: June 3, 2019
Weekly Roundup: May 25, 2019
Weekly Roundup: May 18, 2019
Weekly Roundup: May 12, 2019
Weekly Roundup: May 3, 2019
Weekly Roundup: April 27, 2019
Weekly Roundup: April 22, 2019
Weekly Roundup: April 12, 2019
Weekly Roundup: March 28, 2019
Weekly Roundup: March 22, 2019
Weekly Roundup: March 15, 2019
Weekly Roundup: March 8, 2019
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain